Clinical Trial Update: Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating C1-esterase inhibitor to reduce systemic inflammation in trauma patients with femur or pelvic fractures was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome
• Sepsis

Drugs mentioned

• C1-esterase inhibitor

Snippet

Sponsor: UMC Utrecht | Conditions: Trauma, Inflammation | Phase 3 | Status: TERMINATED